MTHRY Company Profile and Key Details
M3
Price Chart
Stock Price Today
M3, Inc. (MTHRY) stock declined over -3.55%, trading at $6.53 on OTC, down from the previous close of $6.77. The stock opened at $6.53, fluctuating between $6.50 and $6.54 in the recent session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
Annual Report (10-k)
Stock Price History Chart
Contact Details
About Company
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Company Information
| Employees | 12100 |
| Beta | 0.66 |
| Sales or Revenue | $284.90B |
| 5Y Sales Change% | 1.173% |
| Fiscal Year Ends | March |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Stock Peers
Technical Performance
Financial & Profitability Overview
On valuation metrics, M3 trades at a P/E of 39.33, P/S of 5.87 and P/B of 3.74. The current ratio is 2.70 and quick ratio is 2.70. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -143.95 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.08, supported by a cash flow-to-debt ratio of 0.00.
Quarterly Financial Highlights
The company ended the quarter with $134.93B in cash and short-term investments, a total debt of $24.42B, and net debt of - $110.51B. Total assets were $581.74B, with equity of $412.80B. Financials further reflected solid fundamentals, with operating cash flow of $51.74B, free cash flow of $45.45B, and capital expenditures of - $6.29B.
Frequently Asked Questions
Chief Executive Officer of M3 EU
Mr. Itaru Tanimura
Pres and Representative Director
Mr. Paul J. Rice
Chief Operating Officer of European Operations
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep